跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Everolimus Tablets
Approved
化学药品
Everolimus Tablets
Novartis Pharma Schweiz AG
🇨🇳 National Medical Products Administration
Approval Date
Mar 30, 2022
Approval ID
8FWSEb5mpaG
Company
Novartis Pharma Schweiz AG
Type
化学药品
Approval Details
Approval Id
8FWSEb5mpaG
Approval Number
国药准字HJ20171146
Generic Name
依维莫司片
Generic Name En
Everolimus Tablets
Trade Name
飞尼妥
Drug Type
化学药品
Dosage Form
片剂
Strength
10mg
Reg Date
2022-03-30
Expired Date
2027-03-29
Company Name
Novartis Pharma Schweiz AG
Company Address
6343 Risch, Switzerland
Production Company Name
Novartis Pharma Stein AG
Production Company Address
Schaffhauserstrasse, 4332 Stein, Switzerland
Company Detail Path
/organization/novartis-pharma-schweiz-ag
Production Company Detail Path
/organization/novartis-pharma-stein-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 30, 2022
Approval ID
8FWSEb5mpaG
Type
化学药品
Back to NMPA Approvals
飞尼妥 - NMPA Drug Approval Details